InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Inrig Jula, Directeur Médical. Director active across 1 company, notably Travere Therapeutics, Inc.. Aggregated, 18 reports have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €520k. History available since 1 January 2022. The latest transaction was disclosed on 13 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Inrig Jula
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
14,000 shares0Common StockSEC:0001902368-26-000005:0
7,215 shares@ US$41.92880.0054% mcap64.4% of flowCommon StockSEC:0001902368-26-000005:1
1,018 shares@ US$42.610.0008% mcap9.2% of flowCommon StockSEC:0001902368-26-000005:2
1,547 shares@ US$32.116.6% of flowCommon StockSEC:0001902368-26-000004:0
28,130 shares0Common StockSEC:0001902368-26-000003:0
2,031 shares@ US$40.1811.0% of flowCommon StockSEC:0001902368-26-000002:0
15,000 shares@ US$8.9321.8% of flowCommon StockSEC:0001902368-25-000005:0
815 shares@ US$14.652.5% of flowCommon StockSEC:0001415889-25-019108:0
8,000 sharesCommon StockSEC:0001415889-25-003819:0
30,000 shares0Common StockSEC:0001415889-25-003064:0
2,066 shares@ US$19.1036.7% of flowCommon StockSEC:0001415889-25-000899:0
684 shares@ US$12.987.7% of flowCommon StockSEC:0001415889-24-023128:0
6,750 shares0Common StockSEC:0001415889-24-023093:0
25,000 shares0Common StockSEC:0001415889-24-002281:0
2,069 shares@ US$9.479417.1% of flowCommon StockSEC:0001209191-24-001005:0
20,250 shares0Common StockSEC:0001209191-23-006420:0
2,051 shares@ US$20.7538.5% of flowCommon StockSEC:0001209191-23-002325:0
20,000 shares0Common StockSEC:0001209191-22-001117:0
18 of 18 declarations
About Inrig Jula
Inrig Jula is Chief Medical Officer at Travere Therapeutics, Inc. Across 18 filings in total, the 18 sampled filings cover the period from 2022-01-04 to 2026-04-15 and show EUR 519750 of sales, with Cession as the modal transaction nature.
